BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 17706969)

  • 1. Preferential existence of death-inducing proteins in the human cardiomyopathic left ventricle.
    Dzimiri N; Afrane B; Canver CC
    J Surg Res; 2007 Oct; 142(2):227-32. PubMed ID: 17706969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential functional expression of human myocardial G protein receptor kinases in left ventricular cardiac diseases.
    Dzimiri N; Muiya P; Andres E; Al-Halees Z
    Eur J Pharmacol; 2004 Apr; 489(3):167-77. PubMed ID: 15087239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of left ventricular volume overload on mitochondrial and death-receptor-mediated apoptotic pathways in the transition to heart failure.
    Moorjani N; Westaby S; Narula J; Catarino PA; Brittin R; Kemp TJ; Narula N; Sugden PH
    Am J Cardiol; 2009 May; 103(9):1261-8. PubMed ID: 19406269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Programmed cell death in idiopathic dilated cardiomyopathy is mediated by suppression of the apoptosis inhibitor Apollon.
    Aharinejad S; Andrukhova O; Lucas T; Zuckermann A; Wieselthaler G; Wolner E; Grimm M
    Ann Thorac Surg; 2008 Jul; 86(1):109-14; discussion 114. PubMed ID: 18573408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Left-ventricular expression of interleukin-6 messenger-RNA higher in idiopathic dilated than in ischemic cardiomyopathy.
    Plenz G; Song ZF; Reichenberg S; Tjan TD; Robenek H; Deng MC
    Thorac Cardiovasc Surg; 1998 Aug; 46(4):213-6. PubMed ID: 9776495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Description of a local cardiac adiponectin system and its deregulation in dilated cardiomyopathy.
    Skurk C; Wittchen F; Suckau L; Witt H; Noutsias M; Fechner H; Schultheiss HP; Poller W
    Eur Heart J; 2008 May; 29(9):1168-80. PubMed ID: 18390538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TNF-related apoptosis-inducing ligand and its decoy receptor osteoprotegerin in nonischemic dilated cardiomyopathy.
    Schoppet M; Ruppert V; Hofbauer LC; Henser S; Al-Fakhri N; Christ M; Pankuweit S; Maisch B
    Biochem Biophys Res Commun; 2005 Dec; 338(4):1745-50. PubMed ID: 16288714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphometrical analysis of autopsy hearts of congestive cardiomyopathy.
    Tanaka M; Matsubara O; Kajita A; Hatakeyama S
    Bull Tokyo Med Dent Univ; 1983 Sep; 30(3):73-94. PubMed ID: 6589085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DR5 and DcR2 are expressed in human lumbar intervertebral discs.
    Chen B; Ma B; Yang S; Xing X; Gu R; Hu Y
    Spine (Phila Pa 1976); 2009 Sep; 34(19):E677-81. PubMed ID: 19730199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A potential link between peroxisome proliferator-activated receptor signalling and the pathogenesis of arrhythmogenic right ventricular cardiomyopathy.
    Djouadi F; Lecarpentier Y; Hébert JL; Charron P; Bastin J; Coirault C
    Cardiovasc Res; 2009 Oct; 84(1):83-90. PubMed ID: 19497962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between left atrial myocardial function and exercise capacity in patients with either idiopathic or ischemic dilated cardiomyopathy: a two-dimensional speckle strain study.
    D'Andrea A; Caso P; Romano S; Scarafile R; Cuomo S; Salerno G; Riegler L; Limongelli G; Di Salvo G; Romano M; Liccardo B; Iengo R; Ascione L; Del Viscovo L; Calabrò P; Calabrò R
    Int J Cardiol; 2009 Mar; 132(3):354-63. PubMed ID: 18255178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A molecular approach to apoptosis in the human heart during brain death.
    Pérez López S; Vázquez Moreno N; Escudero Augusto D; Astudillo González A; Alvarez Menéndez F; Goyache Goñi F; Otero Hernández J
    Transplantation; 2008 Oct; 86(7):977-82. PubMed ID: 18852665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Marked differences between atrial and ventricular gene-expression remodeling in dogs with experimental heart failure.
    Cardin S; Pelletier P; Libby E; Le Bouter S; Xiao L; Kääb S; Demolombe S; Glass L; Nattel S
    J Mol Cell Cardiol; 2008 Dec; 45(6):821-31. PubMed ID: 18805423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longer preservation of cardiac performance by sheet-shaped myoblast implantation in dilated cardiomyopathic hamsters.
    Kondoh H; Sawa Y; Miyagawa S; Sakakida-Kitagawa S; Memon IA; Kawaguchi N; Matsuura N; Shimizu T; Okano T; Matsuda H
    Cardiovasc Res; 2006 Feb; 69(2):466-75. PubMed ID: 16423569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptomal analysis of failing and nonfailing human hearts.
    Steenman M; Chen YW; Le Cunff M; Lamirault G; Varró A; Hoffman E; Léger JJ
    Physiol Genomics; 2003 Jan; 12(2):97-112. PubMed ID: 12429867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of canine mitochondrial protein expression in natural and induced forms of idiopathic dilated cardiomyopathy.
    Lopes R; Solter PF; Sisson DD; Oyama MA; Prosek R
    Am J Vet Res; 2006 Jun; 67(6):963-70. PubMed ID: 16740088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations in myocardial tissue factor expression and cellular localization in dilated cardiomyopathy.
    Szotowski B; Goldin-Lang P; Antoniak S; Bogdanov VY; Pathirana D; Pauschinger M; Dörner A; Kuehl U; Coupland S; Nemerson Y; Hummel M; Poller W; Hetzer R; Schultheiss HP; Rauch U
    J Am Coll Cardiol; 2005 Apr; 45(7):1081-9. PubMed ID: 15808768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NADPH oxidase-dependent redox signaling in human heart failure: relationship between the left and right ventricle.
    Nediani C; Borchi E; Giordano C; Baruzzo S; Ponziani V; Sebastiani M; Nassi P; Mugelli A; d'Amati G; Cerbai E
    J Mol Cell Cardiol; 2007 Apr; 42(4):826-34. PubMed ID: 17346742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential role of antibodies against cardiac Kv channel-interacting protein 2 in dilated cardiomyopathy.
    Landsberger M; Staudt A; Choudhury S; Trimpert C; Herda LR; Klingel K; Kandolf R; Schultheiss HP; Kroemer HK; Völker U; Felix SB
    Am Heart J; 2008 Jul; 156(1):92-99.e2. PubMed ID: 18585502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional heterogeneity of decreased myocardial norepinephrine and increased lipid peroxidation levels in patients with end-stage failing heart secondary to dilated or ischemic cardiomyopathy.
    Rochette L; Tatou E; Vergely C; Maupoil V; Bouchot O; Mossiat C; Jazayeri S; Benkhadra S; Brenot R; Girard C; David M
    J Heart Lung Transplant; 2008 Jul; 27(7):767-74. PubMed ID: 18582807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.